top of page
1/4
Preventing chemotherapy-induced gut toxicities and inflammation
OUR MISSION
To improve lower gastrointestinal health by preventing chemotherapy-induced toxicities and inflammation caused due to dietary, xenobiotics and genetic factors.
September 2021
-
Sanarentero Awarded Phase I STTR award $400,000 for National Cancer Institute to Develop Drug Detoxifying Bacteria to Prevent Chemotherapy-induced Diarrhea
Our current technologies for gut protection are Drug detoxifying bacteria and Proprietary Botanical Product.
Interested investors can connect with us for further collaboration with our company.
bottom of page